Pluronic diacrylate macromer, and alginate |
DIW: Nozzle diameter—400 µm; nozzle temperature—25 °C; print speed—15 mm/s; pressure—0.04 kPa; bed temperature—60 °C |
UV curing |
Square mesh to folded mesh |
Methotrexate—Co-mixing |
Ion (Calcium chloride) |
Fast release up to 6 h followed by steady release up to 12 h |
[148] |
Gelatin methacryloyl |
DIW: Nozzle diameter—210 µm; nozzle temperature—26 °C; print speed—20 mm/s |
UV curing |
Sheet to tubular |
Heparin—Co-mixing |
Solvent (Water) |
Fast release up to 8 h followed by steady release up to 28 h |
[149] |
Poly(N-isopropylacrylamide) |
DIW: Nozzle diameter—340 µm |
UV curing |
Expanding core–shell capsules |
Brilliant blue and lemon yellow—Injection |
Temperature (22 °C) |
Fast release up to 15 h followed by medium release up to 48 h |
[150] |
Poly(vinyl alcohol) |
FDM: Nozzle diameter—400 µm; nozzle temperature—180 °C; print speed—23 mm/s |
- |
I to U, U to I, and helix to extended conformation |
Caffeine—Co-mixing |
Solvent (Water) |
Fast release up to 2 h followed by steady release up to 6 h |
[151] |
Methacrylamide Chitosan |
2PP: Sub-micron resolution |
- |
Expandable microswimmers |
Doxorubicin—Immersion |
Light (UV 365 nm) |
Fast release up to 1 min (light ON) followed by steady release up to 6 min (light OFF) |
[152] |
Gelatin methacryloyl |
2PP: Sub-micron resolution |
- |
Expandable microswimmers |
Fluorescein isothiocyanate—Immersion |
Enzyme (Metallo-proteinase 2) |
Fast release up to 2 h followed by medium release up to 48 h |
[153] |
Poly(ethylene glycol) diacrylate |
µSLA: Layer thicknesss—50 µm |
UV curing |
Straight to backward-facing curved barbs in microneedle array |
Rhodamine B—Immersion |
Ion (Phosphate buffered saline) |
Fast release in 1 min followed by medium release up to 2.5 h, and slow releases up to 3 h |
[154] |
4-hydroxybutyl acrylate, and urethanepolyethylene glycol-polypropylene glycol |
DLP: Layer thicknesss—100 µm |
UV curing |
Stretchable nerve guide tubing |
Doxorubicin, and ovalbumin—Immersion |
Magnetic field (1 MHz) |
Fast release in 4 h (doxorubicin) or 30 min (ovalbumin) followed by medium release up to 50 h, and steady releases up to 75 h |
[155] |